Our laboratory initially identified MYBL1 gene overexpression in a subset of TNBC cell lines following meta-analyses of breast cancers processed using DNA microarrays deposited at Gene Expression Omnibus (GEO) [14]. The gene discussed is MYBL1; the disease is breast carcinoma.